TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial–mesenchymal transition in Sjögren's syndrome

SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7

Gareth J. Inman, Francisco José Nicolás, James F. Callahan et al. · Molecular Pharmacology · 2002 · 1.7K citations

Life Sciences, Molecular Biology, Pharmacology +13

EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration

Nicole M. Aiello, Ravikanth Maddipati, Robert J. Norgard et al. · Developmental Cell · 2018 · 747 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

Fanli Meng, Kai Wang, Tomonori Aoyama et al. · Gastroenterology · 2012 · 697 citations · Full text

Life Sciences, Immunology, Pathology +14

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur et al. · Molecular Pharmacology · 2002 · 650 citations

Life Sciences, Molecular Biology, Pharmacology +16

Activation of the Erk Pathway Is Required for TGF-β1-Induced EMT In Vitro

Lu Xie, Brian K. Law, Anna Chytil et al. · Neoplasia · 2004 · 533 citations · Full text

Life Sciences, Cell Biology, Oncology +17